{{expand|time=2015-09-26T01:22:20+00:00}}
{{unreferenced|time=2015-09-26T01:22:20+00:00}}
{{Drugbox
| verifiedrevid = 462080585
| IUPAC_name = (''RS'')-2-([4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl)-1''H''-benzo[''d'']imidazole
| image = rabeprazole.png
| width = 240
| image2 = rabeprazole3d.png
| width2 = 240
| imagename = 1 : 1 mixture (racemate)
| drug_name = 雷贝拉唑<br>Rabeprazole
<!--Clinical data-->
| tradename = Aciphex, Acifix (by [[Beximco_Pharma|Beximco]])
| Drugs.com = {{drugs.com|monograph|aciphex}}
| MedlinePlus = a699060
| licence_US = AcipHex Finix
| pregnancy_US = B
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = 口服
<!--Pharmacokinetic data-->
| bioavailability = 52%
| metabolism = 大部分不经酶催化代谢<br />一部分通过[[肝脏|肝脏]] ([[CYP2C19|CYP2C19]])
| elimination_half-life = 1 - 1.5 小时
| excretion = 90% [[肾脏|肾脏]]
<!--Identifiers-->
| IUPHAR_ligand = 7290
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 117976-89-3
| ATC_prefix = A02
| ATC_suffix = BC04
| PubChem = 5029
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01129
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4853
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 32828355LL
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 8768
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1219
| PDB_ligand = RZX
<!--Chemical data-->
| C=18 | H=21 | N=3 | O=3 | S=1
| molecular_weight = 359.444 g/mol
| smiles = O=S(c2nc1ccccc1n2)Cc3nccc(OCCCOC)c3C
| InChI = 1/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)
| InChIKey = YREYEVIYCVEVJK-UHFFFAOYAY
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = YREYEVIYCVEVJK-UHFFFAOYSA-N
}}
{{medical}}
'''雷贝拉唑（{{lang-en|Rabeprazole}}）'''是一种[[质子泵抑制剂|质子泵抑制剂]]（PPI）类[[胃酸抑制剂|胃酸抑制剂]]。由[[Eisai_Co.|Eisai Co.]]公司开发并且现已广泛使用。

==适应证==
雷贝拉唑可以短期内缓解[[十二指肠溃疡|十二指肠溃疡]]和[[胃食管反流病|胃食管反流病]]的症状，并且可以缓解[[烧心|烧心]]，也可以与抗生素联用根除[[幽门螺杆菌|幽门螺杆菌]]。
[[File:Aciphex-sample-bottle.jpg|缩略图]]

==引用==
{{reflist}}

{{消化道溃疡和胃食管反流病治疗药物}}

[[Category:质子泵抑制剂|Category:质子泵抑制剂]]